These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 28890187)

  • 21. Unidirectional peristaltic movement in multisite drug binding pockets of AcrB from molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    Mol Biosyst; 2012 Oct; 8(10):2699-709. PubMed ID: 22825052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.
    Hayashi K; Nakashima R; Sakurai K; Kitagawa K; Yamasaki S; Nishino K; Yamaguchi A
    J Bacteriol; 2016 Jan; 198(2):332-42. PubMed ID: 26527645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AcrB: a mean, keen, drug efflux machine.
    Kobylka J; Kuth MS; Müller RT; Geertsma ER; Pos KM
    Ann N Y Acad Sci; 2020 Jan; 1459(1):38-68. PubMed ID: 31588569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RND efflux pumps: structural information translated into function and inhibition mechanisms.
    Ruggerone P; Murakami S; Pos KM; Vargiu AV
    Curr Top Med Chem; 2013; 13(24):3079-100. PubMed ID: 24200360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.
    Elkins CA; Nikaido H
    J Bacteriol; 2002 Dec; 184(23):6490-8. PubMed ID: 12426336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between AcrB trimer association affinity and efflux activity.
    Ye C; Wang Z; Lu W; Zhong M; Chai Q; Wei Y
    Biochemistry; 2014 Jun; 53(23):3738-46. PubMed ID: 24854514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug uptake pathways of multidrug transporter AcrB studied by molecular simulations and site-directed mutagenesis experiments.
    Yao XQ; Kimura N; Murakami S; Takada S
    J Am Chem Soc; 2013 May; 135(20):7474-85. PubMed ID: 23627437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proximal Binding Pocket Arg717 Substitutions in Escherichia coli AcrB Cause Clinically Relevant Divergencies in Resistance Profiles.
    Zwama M; Nishino K
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0239221. PubMed ID: 35311521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the inhibitors phenylalanine arginyl ß-naphthylamide (PAßN) and 1-(1-naphthylmethyl)-piperazine (NMP) on expression of genes in multidrug efflux systems of Escherichia coli isolates from bovine mastitis.
    Barrero MA; Pietralonga PA; Schwarz DG; Silva A; Paula SO; Moreira MA
    Res Vet Sci; 2014 Oct; 97(2):176-81. PubMed ID: 24992822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter.
    Cha HJ; Müller RT; Pos KM
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4767-72. PubMed ID: 24914123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB.
    Bohnert JA; Schuster S; Seeger MA; Fähnrich E; Pos KM; Kern WV
    J Bacteriol; 2008 Dec; 190(24):8225-9. PubMed ID: 18849422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ structure and assembly of the multidrug efflux pump AcrAB-TolC.
    Shi X; Chen M; Yu Z; Bell JM; Wang H; Forrester I; Villarreal H; Jakana J; Du D; Luisi BF; Ludtke SJ; Wang Z
    Nat Commun; 2019 Jun; 10(1):2635. PubMed ID: 31201302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli.
    Lim SP; Nikaido H
    Antimicrob Agents Chemother; 2010 May; 54(5):1800-6. PubMed ID: 20160052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants.
    Ciusa ML; Marshall RL; Ricci V; Stone JW; Piddock LJV
    J Antimicrob Chemother; 2022 Feb; 77(3):633-640. PubMed ID: 34897478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding site feature description of 2-substituted benzothiazoles as potential AcrAB-TolC efflux pump inhibitors in E. coli.
    Yilmaz S; Altinkanat-Gelmez G; Bolelli K; Guneser-Merdan D; Ufuk Over-Hasdemir M; Aki-Yalcin E; Yalcin I
    SAR QSAR Environ Res; 2015; 26(10):853-71. PubMed ID: 26559566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant Impact of AcrB Amino Acid Polymorphism at Residue 716 on Susceptibility to Tigecycline and Other Antibiotics in
    Wang W; Ma Y; Ma Y; Zheng X; Yu J; Li L; Liu X; Gao H; Xu H; Wang M
    ACS Infect Dis; 2024 Feb; 10(2):541-552. PubMed ID: 38181222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump.
    Ohene-Agyei T; Mowla R; Rahman T; Venter H
    Microbiologyopen; 2014 Dec; 3(6):885-96. PubMed ID: 25224951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC.
    Li B; Yao Q; Pan XC; Wang N; Zhang R; Li J; Ding G; Liu X; Wu C; Ran D; Zheng J; Zhou H
    J Antimicrob Chemother; 2011 Apr; 66(4):769-77. PubMed ID: 21393180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance.
    Seeger MA; Diederichs K; Eicher T; Brandstätter L; Schiefner A; Verrey F; Pos KM
    Curr Drug Targets; 2008 Sep; 9(9):729-49. PubMed ID: 18781920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.